3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
2
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Interventions
Afatinib
3
ceritinib
2
Gefitinib
2
zipalertinib
1
zenocutuzumab
1
ulixertinib
1
trilaciclib
1
telisotuzumab vedotin
1
tazemetostat
1
taletrectinib
1
sotorasib
1
selpercatinib
1
rovalpituzumab tesirine
1
rociletinib
1
pralsetinib
1
pegilodecakin
1
patritumab deruxtecan
1
osimertinib
1
mobocertinib
1
lorlatinib
1
lazertinib
1
epigallocatechin gallate
1
ensartinib
1
dabrafenib
1
cemiplimab
1
capmatinib
1
brigatinib
1
belagenpumatucel L
1
balstilimab
1
amivantamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
taletrectinib
×
Thoracic
×
Clear all
NCT06841874
2025-12-24
Tale EAP
Nuvation Bio Inc.
No longer available